PCM
CABA icon

Penserra Capital Management’s Cabaletta Bio CABA Stock Holding History

Penserra Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-570
Closed -$6K – 1391
2021
Q3 		$6K Buy
570
+5
+0.9% +$46 ﹤0.01% 1400
2021
Q2 		$4K Buy
565
+20
+4% +$197 ﹤0.01% 1321
2021
Q1 		$6K Sell
545
-5
-0.9% -$61 ﹤0.01% 1073
2020
Q4 		$6K Buy
+550
New +$7.13K ﹤0.01% 969

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Penserra Capital Management's CABA Position: Q4 2021 in Review

Penserra Capital Management sold out of Cabaletta Bio (CABA) in Q4 2021, closing a stake of 570 shares — an estimated $6K sold.

Penserra Capital Management first reported a position in CABA in Q4 2020 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 66 funds tracked by Wall St. Rank hold CABA as of Q4 2021.

  • Penserra Capital Management reported no remaining Cabaletta Bio position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 570 Cabaletta Bio shares in Q4 2021, an estimated $6K.
  • Penserra Capital Management first reported a position in Cabaletta Bio in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Cabaletta Bio position peaked at $6K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.